Fidelity Investments
IRD icon

Fidelity Investments’s Opus Genetics IRD Stock Holding History

Fidelity Investments’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$626K Buy
129,404
+129,262
+91,030% +$537K ﹤0.01% 3215
2026
Q2 		$584 Buy
142
+134
+1,675% +$625 ﹤0.01% 5300
2026
Q1 		$36 Buy
+8
New +$28 ﹤0.01% 5316
2025
Q1 		– Sell
-1
Closed -$1 – 5762
2024
Q4 		$1 Buy
+1
New +$1 ﹤0.01% 5518
2023
Q3 		– Sell
-100
Closed -$434 – 5561
2023
Q2 		$434 Buy
+100
New +$475 ﹤0.01% 4830

Other funds holding IRD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
BIOS Capital Management
BIOS Capital Management Fort Worth, Texas $34.2M AUM 13.29% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
AIC
AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return
Blue Owl Capital Holdings
Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

Fidelity Investments's IRD Position: Q3 2026 in Review

Fidelity Investments increased its Opus Genetics (IRD) stake by 91,030% in Q3 2026, buying an estimated $537K and bringing the position to 129,404 shares worth $626K. The position accounts for ﹤0.01% of the portfolio, ranked #3215.

Fidelity Investments first reported a position in IRD in Q2 2023 and has held it in 5 quarters since. 74 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Fidelity Investments held 129,404 shares of Opus Genetics worth $626K as of Q3 2026.
  • Fidelity Investments bought 129,262 Opus Genetics shares in Q3 2026, an estimated $537K.
  • Opus Genetics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #3215 holding.
  • Fidelity Investments first reported a position in Opus Genetics in Q2 2023 and has held it in 5 quarters since.
  • 74 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.